Sponsor or institution
Clinical trials and research at CanSino Biologics Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by CanSino Biologics Inc. that are recruiting, in China. By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
24-valent pneumococcal vaccine test in infants, children, and adults
This trial tests a 24-valent pneumococcal vaccine (CRM197/tetanus toxoid) to see if it is safe and can provoke an immune response in people from 2 months old to 50+ years old.
-
Combined DTaP-Hib and Meningococcal ACYW135 vaccine for infants and children
This trial tests a combined vaccine that protects against diphtheria, tetanus, pertussis, Haemophilus influenzae type b, and meningococcal ACYW135 in children aged 2 months to 6 years to see if it is safe and prompts an immune response.
Quick answers
How many clinical trials run by CanSino Biologics Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.